127 related articles for article (PubMed ID: 3898823)
1. Heparin-mediated neutralization of platelet antiaggregatory activity of prostacyclin (PGI2): studies on mechanism.
Saba SR; Saba HI
Am J Hematol; 1985 Oct; 20(2):97-105. PubMed ID: 3898823
[TBL] [Abstract][Full Text] [Related]
2. Effect of heparin on platelet aggregation.
Saba HI; Saba SR; Morelli GA
Am J Hematol; 1984 Oct; 17(3):295-306. PubMed ID: 6475940
[TBL] [Abstract][Full Text] [Related]
3. Heparin neutralization of PGI2: effects upon platelets.
Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
[TBL] [Abstract][Full Text] [Related]
4. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
Jaschonek K; Faul C; Daiss W; Weisenberger H
Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
Callahan KS; Johnson AR; Campbell WB
Circulation; 1985 Jun; 71(6):1237-46. PubMed ID: 2986877
[TBL] [Abstract][Full Text] [Related]
6. Effect of heparin on platelet aggregation inhibited by PGI2, trifluoperazine and verapamil.
Weber DR; Nichols WK; Mohammad SF
Thromb Res; 1986 May; 42(4):477-87. PubMed ID: 3012821
[TBL] [Abstract][Full Text] [Related]
7. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
[TBL] [Abstract][Full Text] [Related]
8. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
Miller OV; Aiken JW; Shebuski RJ; Gorman RR
Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
[TBL] [Abstract][Full Text] [Related]
9. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG
Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968
[TBL] [Abstract][Full Text] [Related]
10. The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function.
Levin RI; Weksler BB; Jaffe EA
Circulation; 1982 Dec; 66(6):1299-307. PubMed ID: 6291803
[TBL] [Abstract][Full Text] [Related]
11. The single prostacyclin receptor of gel-filtered platelets provides a correlation with antiaggregatory potency of PGI2 mimics.
Eggerman TL; Hartzell CJ; Selfe S; Andersen NH
Thromb Res; 1987 Mar; 45(5):645-59. PubMed ID: 3296302
[TBL] [Abstract][Full Text] [Related]
12. Dextran 40 reduces heparin-mediated platelet aggregation.
Sobel M; Adelman B; Greenfield LJ
J Surg Res; 1986 Apr; 40(4):382-7. PubMed ID: 2422443
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.
Wong PY; Lee WH; Chao PH; Reiss RF; McGiff JC
J Biol Chem; 1980 Oct; 255(19):9021-4. PubMed ID: 6997309
[TBL] [Abstract][Full Text] [Related]
14. Heparin-enhanced plasma phospholipase A2 activity and prostacyclin synthesis in patients undergoing cardiac surgery.
Nakamura H; Kim DK; Philbin DM; Peterson MB; Debros F; Koski G; Bonventre JV
J Clin Invest; 1995 Mar; 95(3):1062-70. PubMed ID: 7883954
[TBL] [Abstract][Full Text] [Related]
15. Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function.
Rao GH; Reddy KR; Hagert K; White JG
Prostaglandins Med; 1980 Apr; 4(4):263-73. PubMed ID: 6994159
[TBL] [Abstract][Full Text] [Related]
16. 6-keto PGE1: a possible metabolite of prostacyclin having platelet antiaggregatory effects.
Quilley CP; McGiff JC; Lee WH; Sun FF; Wong PY
Hypertension; 1980; 2(4):524-8. PubMed ID: 6995292
[TBL] [Abstract][Full Text] [Related]
17. Protamine-induced platelet aggregation and clotting investigated by ultrasound.
Machi J; Sigel B; Feinberg H
Haemostasis; 1987; 17(4):226-34. PubMed ID: 3114103
[TBL] [Abstract][Full Text] [Related]
18. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
Coppe D; Sobel M; Seamans L; Levine F; Salzman E
J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
[TBL] [Abstract][Full Text] [Related]
19. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
Hermán F; Hadházy P; Magyar K
Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
[TBL] [Abstract][Full Text] [Related]
20. Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets.
Salari H; Duronio V; Howard S; Demos M; Pelech SL
Biochem J; 1990 May; 267(3):689-96. PubMed ID: 2160234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
